MIAMI, FL USA (UroToday.com) - It was interesting to see several research posters that involved male subjects and prostate research. This was one of them.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The study’s objective was to evaluate outcomes, efficacy, and safety in male patients with prostate volumes larger and smaller than 100mL. Three-hundred sixty-two patients underwent photoselective vaporization of the prostate (PVP) with the 180W XPS Greenlight laser from July 2010 to June 2012 at 2 institutions -- Weill Cornell, Medical College, USA and University Hospital Basel, Switzerland. Patients with a prostate volume of ≥ 100ml were older (75.3 vs. 71.0 years p=0.005) and had a higher rate of preoperative retention (53.0% vs. 29.6%; p<0.001) compared to patients with smaller prostate volumes. Postoperatively, micturition symptoms (IPSS, QoL) and voiding parameters (Qmax, postvoid residual volume) improved in both groups of patients, with no significant differences noted in the relative improvements.
Over a follow-up of 2 years, the rates of postoperative urinary tract infection, postoperative retention, urethral stricture, and reoperation did not differ between the 2 groups. The authors concluded that PVP with the 180W XPS Greenlight™ laser is a safe and effective minimal-invasive treatment option for patients with large prostate volumes. Operative times and laser energy requirements are higher in patients with larger prostates, but this did not increase adverse events.
Presented by Daniel J. Lee, Malte Rieken, Fujun Zhao, Heike Pueschel, Bilal Chughtai, Steven A. Kaplan, Alexis E. Te, Alexander Bachmann, and Richard K. Lee at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Winter Meeting - February 25 - March 1, 2014 - Doral Golf Resort and Spa - Miami, Florida USA
Department of Urology, Weill Cornell Medical College, New York, NY, USA
Department of Urology, University Hospital Basel, Basel, Switzerland
Reported for UroToday.com by Diane K. Newman, DNP, FAAN, BCB-PMD